Your shopping cart is currently empty

TCJL37, a potent, selective, and orally bioavailable inhibitor of TYK2, exhibits a K i value of 1.6 nM. It is useful for researching inflammatory bowel diseases (IBD) [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $787 | 35 days | 35 days |
| Description | TCJL37, a potent, selective, and orally bioavailable inhibitor of TYK2, exhibits a K i value of 1.6 nM. It is useful for researching inflammatory bowel diseases (IBD) [1]. |
| Targets&IC50 | Tyk2:1.6 nM (Ki) |
| In vitro | In cell-based assays, TCJL37 (Compound 37) demonstrates an IL-12 pSTAT4 EC50 of 224 nM. Additionally, it shows EC50 values of 168 nM in human peripheral blood mononuclear cells (PBMC) and 737 nM in human whole blood assays [1]. |
| In vivo | TCJL37 shows high oral bioavailability in CD-1 mice when administered orally at a dosage of 100 mg/kg. Additionally, TCJL37 exhibits low metabolic clearance, measured at 1.0 mL/min/kg, in rats [1]. |
| Molecular Weight | 376.74 |
| Formula | C17H11ClF2N4O2 |
| Cas No. | 1258294-34-6 |
| Smiles | N(C(=O)C1=C(Cl)C=C(C#N)C=C1F)C=2C=C(NC(=O)[C@@H]3[C@H](F)C3)N=CC2 |
| Relative Density. | 1.53 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.